September 25, 2018
5 min watch
Save

VIDEO: Specialist speaks about use of anti-VEGFs in myopic CNV

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

VIENNA — Pathologic myopia is a widespread condition in Hong Kong and a leading cause of blindness in many Asian countries. At the Euretina meeting, Timothy Lai, MD, speaks about the use of anti-VEGFs in myopic choroidal neovascularization.